6533b871fe1ef96bd12d113a

RESEARCH PRODUCT

Bioinformatic and experimental fishing for artemisinin-interacting proteins from human nasopharyngeal cancer cells.

Thomas EfferthR L Krauth-siegelTolga EichhornRolf MertensB HahnWolf-dieter LehmannA WendlerS Schloissnig

subject

ProteomicsCell cycle checkpointCell growthAngiogenesisComputational BiologyCell migrationApoptosisNasopharyngeal NeoplasmsCell Cycle CheckpointsBiologyProteomicsArtemisininsCell biologyNeoplasm ProteinsNuclear receptorCell cultureCell Line TumormedicineAnticarcinogenic AgentsHumansArtemisininMolecular BiologyBiotechnologymedicine.drugCell Proliferation

description

Determining interacting cellular partners of drugs by chemical proteomic techniques is complex and tedious. Most approaches rely on activity-based probe profiling and compound-centric chemical proteomics. The anti-malarial artemisinin also exerts profound anti-cancer activity, but the mechanisms of action are incompletely understood. In the present investigation, we present a novel approach to identify artemisinin-interacting target proteins. Our approach overcomes usual problems in traditional fishing procedures, because the drug was attached to a surface without further chemical modification. The proteins identified effect among others, cell cycle arrest, apoptosis, inhibition of angiogenesis, disruption of cell migration, and modulation of nuclear receptor responsiveness. Furthermore, a bioinformatic approach confirmed experimentally identified proteins and suggested a large number of other interacting proteins. Theoretically predicted interaction partners may serve as a starting point to complete the whole set of proteins binding artemisinin.

10.1039/c2mb05437jhttps://pubmed.ncbi.nlm.nih.gov/22311186